Insider Trading & Ownership - Flagship Ventures Fund IV-Rx L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Flagship Ventures Fund IV-Rx L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-27
Purchase
2022-06-01
7:00 pm
Evelo Biosciences Inc. EVLO Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
Nutritional Health LTP Fund General Partner LLC
Nutritional Health LTP Fund L.P.
Flagship Pioneering Inc.
AFEYAN NOUBAR
10% Owner
27,397,259 $1.46 $39,999,998 27,233,921
(Indirect)
View
2022-03-16
Purchase
2022-03-18
08:30 am
Axcella Health Inc. AXLA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
AFEYAN NOUBAR
10% Owner
6,319,371 $1.91 $12,069,999 8,262,725
(Indirect)
View
2021-02-02
Purchase
2021-02-04
5:56 pm
Evelo Biosciences Inc. EVLO Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
Nutritional Health LTP Fund General Partner LLC
Nutritional Health LTP Fund L.P.
AFEYAN NOUBAR
10% Owner
130,000 $15 $1,950,000 17,660,752
(Indirect)
View
2020-06-29
Purchase
2020-07-01
5:24 pm
Evelo Biosciences Inc. EVLO Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
AFEYAN NOUBAR
10% Owner
4,666,666 $3.75 $17,499,998 17,614,323
(Indirect)
View
2020-05-21
Sale
2020-05-26
5:00 pm
Moderna Inc. MRNA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
AFEYAN NOUBAR
Director
10% Owner
1,000,000 $68.22 $68,219,276 19,274,952
(Indirect)
View
2020-05-18
Purchase
2020-05-20
5:15 pm
Axcella Health Inc. AXLA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
AFEYAN NOUBAR
10% Owner
3,800,000 $4.75 $18,050,000 6,682,882
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-11-23
Other
2020-11-25
6:00 pm
N/A
N/A
Seres Therapeutics Inc. MCRB Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Nutritional Health LTP Fund General Partner LLC
Nutritional Health LTP Fund L.P.
Flagship Pioneering Inc.
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VI L.P.
AFEYAN NOUBAR
10% Owner
7,907,179 $0 11,018,191
(Indirect)
View
2020-08-17
Other
2020-08-19
8:15 pm
N/A
N/A
Moderna Inc. MRNA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
AFEYAN NOUBAR
Director
10% Owner
11,053,049 $0 24,619,111
(Indirect)
View
2020-05-11
Other
2020-05-13
6:12 pm
N/A
N/A
Moderna Inc. MRNA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
AFEYAN NOUBAR
Director
10% Owner
12,281,179 $0 25,135,365
(Indirect)
View